InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-17.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Ho Tony W, Vice-Président Exécutif, Responsable de la R&D. Officer active across 1 company, notably CRISPR Therapeutics AG. Cumulatively, 1 filings have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Declarations1 total
26,667 sharesCommon SharesSEC:0001209191-21-068454:0
1 of 1 declaration
About Ho Tony W
Ho Tony W is the Executive VP, Head of R&D at CRISPR Therapeutics AG. He oversees the company's research and development initiatives, ensuring innovation and advancement of scientific projects. Tony brings in-depth expertise in the biotechnology field, contributing to the evolution of gene therapies.
